Rosetta Genomics Ltd. Marketable Securities, Gain (Loss)
Rosetta Genomics Ltd. reported Marketable Securities, Gain (Loss) of $7.00 thousand for the 12-month period ending 2011-12-31, per its 20-F filed 2014-03-31.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2014-03-31
| Period end | Marketable Securities, Gain (Loss) 6 month | Marketable Securities, Gain (Loss) 12 month |
|---|---|---|
| 2011-12-31 | $7.00K 20-F · filed 2014-03-31 | |
| 2011-06-30 | $9.00K 6-K · filed 2012-09-28 | |
| 2010-12-31 | $125.00K 20-F · filed 2013-03-22 | |
| 2009-12-31 | $31.00K 6-K · filed 2012-12-07 |